Medicare Price Inflation Rebates, Part D ‘Redesign’ Proposed In Senate Finance Bill
Executive Summary
Price inflation rebates are expected to generate $50bn in savings over 10 years, according to the Congressional Budget Office.
You may also be interested in...
Senate Democrats Running Out Of Time On Drug Pricing Reform
Is less ambitious drug pricing reform better than nothing? Senate Finance Committee Chair Wyden still pushing for a version of the most aggressive policy, direct government price negotiation.
Trump Administration Signals Deference To Congress On Drug Pricing Policy
In a marked departure from previous years, budget proposal offers few specifics on cost reductions, but the $135bn savings estimate is a tacit endorsement of the Grassley-Wyden bill in the Senate.
Drug Pricing Legislation In The US May Be Losing Momentum
House subcommittee hearing on drug price negotiation bill championed by Speaker Nancy Pelosi showcases strong Republican opposition, and Senate Finance Committee Chairman Chuck Grassley suggests his bill may not be ready for a floor vote until next year.